Oblenio Bio
Specializes in the treatment of autoimmune diseases.
Specializes in the treatment of autoimmune diseases. Headquartered in Cambridge, MA. Raised $62M in Series B funding in June 2026 led by Pfizer Ventures.
Biotechnology
📍 Cambridge, MA
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Oblenio Bio going public?
No. Oblenio Bio is private and has not filed to go public. There is no S-1 on file.
What is Oblenio Bio's valuation in 2026?
No confirmed valuation is on record for Oblenio Bio. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Oblenio Bio filed an S-1?
No public S-1 is on file for Oblenio Bio.
Who are Oblenio Bio's investors?
Oblenio Bio's investors include Pfizer Ventures, Deep Track Capital, GV, Aditum Bio.
How much has Oblenio Bio raised?
Oblenio Bio has raised $62M in total across 1 disclosed round, most recently a Series B of $62M in Jun 2026.
Is Oblenio Bio publicly traded — can you buy Oblenio Bio stock?
No. Oblenio Bio is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Oblenio Bio on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Last Round
Series B — $62M (Jun 2026) · Lead: Pfizer Ventures
Fundraising Status
Series B · $62M · 3 mo ago
privateTotal raised $62M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $62M | Jun 2026 | Pfizer Ventures | — |
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Oblenio Bio — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-19. Re-checked weekly.
Talent Signal
No public careers page or job board could be found for Oblenio Bio as of 2026-09-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
Investors
Pfizer Ventures · Deep Track Capital · GV · Aditum Bio
BiotechnologyPharmaceuticalsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.